The United States and the United Kingdom announced an Agreement in Principle on Pharmaceutical Pricing on December 1, 2025, which exempted specific UK-origin medical technology and pharmaceutical goods from Section 232 tariffs and potential future Section 301 tariffs.

Authors

• Person: Inu Manak, Allison J. Smith Organization: Council on Foreign Relations
  Tracking Trump's Trade Deals | Council on Foreign Relations

Sources

• Tracking Trump's Trade Deals | Council on Foreign Relations www.cfr.org Inu Manak, Allison J. Smith · Council on Foreign Relations via serper

Referenced by nodes (3)

• Section 122 tariffs concept
• U.S. location
• United Kingdom location